[Influence of coronary dilatators on strophanthin toxicity].
D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D003374:Coumarins / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D006016:Glycolates / Q000494:pharmacology*; D007263:Infusions, Parenteral; D007274:Injections, Intraperitoneal; D008297:Male; D009026:Mortality; D010627:Phenethylamines / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology*; D011817:Rabbits; D013328:Strophanthins / Q000008:administration & dosage / Q000633:toxicity*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D000605:Amino Alcohols; D003374:Coumarins; D006016:Glycolates; D010627:Phenethylamines; D011427:Propiophenones; D013328:Strophanthins; D014665:Vasodilator Agents; D004176:Dipyridamole
Uber die Beeinflussung der Strophanthin-Toxizität durch Koronardilatatoren.